Former HCFA Administrator suggests new U.S. agency on comparative clinical effectiveness

"Developing a Center for Comparative Effectiveness Information," Health Affairs: In a Health Affairs Web exclusive, Gail Wilensky -- an economist, senior fellow at Project HOPE and former administrator of the Health Care Financing Administration -- examines the growing interest in the U.S. for unbiased, credible information on comparative clinical effectiveness by those who support competitive health care pricing and by those who support administered pricing.

According to Wilensky, the U.S. should establish an agency for comparative effectiveness information to support better decision making in health care and "provide an independent assessment of comparative effectiveness of medical interventions for use by payers, patients and providers" (Wilensky, Health Affairs, 11/8).

Three perspective pieces responding to Wilensky's article by Kathy Buto and Peter Juhn -- vice president of health policy and executive director of health policy and evidence-based medicine, respectively, at Johnson and Johnson; Carolyn Clancy is director of the Agency for Healthcare Research and Quality; and former Aetna CEO John Rowe of the department of health policy and management at the Columbia University Mailman School of Public Health and colleagues are available online.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare